Selected article for: "disease severity and pan viral DNA microarray"

Author: Chiu, Charles Y.; Rouskin, Silvi; Koshy, Anita; Urisman, Anatoly; Fischer, Kael; Yagi, Shigeo; Schnurr, David; Eckburg, Paul B.; Tompkins, Lucy S.; Blackburn, Brian G.; Merker, Jason D.; Patterson, Bruce K.; Ganem, Don; DeRisi, Joseph L.
Title: Microarray Detection of Human Parainfluenzavirus 4 Infection Associated with Respiratory Failure in an Immunocompetent Adult
  • Cord-id: ci4qg0qu
  • Document date: 2006_10_15
  • ID: ci4qg0qu
    Snippet: A pan-viral DNA microarray, the Virochip (University of California, San Francisco), was used to detect human parainfluenzavirus 4 (HPIV-4) infection in an immunocompetent adult presenting with a life-threatening acute respiratory illness. The virus was identified in an endotracheal aspirate specimen, and the microarray results were confirmed by specific polymerase chain reaction and serological analysis for HPIV-4. Conventional clinical laboratory testing using an extensive panel of microbiologi
    Document: A pan-viral DNA microarray, the Virochip (University of California, San Francisco), was used to detect human parainfluenzavirus 4 (HPIV-4) infection in an immunocompetent adult presenting with a life-threatening acute respiratory illness. The virus was identified in an endotracheal aspirate specimen, and the microarray results were confirmed by specific polymerase chain reaction and serological analysis for HPIV-4. Conventional clinical laboratory testing using an extensive panel of microbiological tests failed to yield a diagnosis. This case suggests that the potential severity of disease caused by HPIV-4 in adults may be greater than previously appreciated and illustrates the clinical utility of a microarray for broad-based viral pathogen screening.

    Search related documents:
    Co phrase search for related documents
    • acid fast bacilli and admission prior: 1
    • acid fast bacilli and admission time: 1, 2
    • acid fast bacilli and lung biopsy: 1
    • acute respiratory syndrome and additional support: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute respiratory syndrome and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung biopsy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute viral pneumonia and admission prior: 1
    • acute viral pneumonia and admission time: 1
    • acute viral pneumonia and lung biopsy: 1
    • additional support and admission time: 1
    • additional support and longitudinal study: 1, 2, 3
    • admission prior and longitudinal study: 1
    • admission prior and lung biopsy: 1, 2, 3
    • admission time and longitudinal study: 1, 2, 3, 4, 5, 6
    • admission time and lung biopsy: 1
    • longitudinal study and lung biopsy: 1